• product_banner

Wholesale Price China Bioantibody - Promote Drug Development Process – Bioantibody

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We keep on with the basic principle of "quality to start with, support very first, continuous improvement and innovation to meet the customers" for your management and "zero defect, zero complaints" as the quality objective. To great our service, we offer the items with all the superior top quality at the reasonable selling price for H Pylori Antibody Blood Test, Rbd Domain Of Spike Protein, Rapid Test Antigen Solo, Our products are new and old customers consistent recognition and trust. We welcome new and old customers to contact us for future business relations, common development. Let's speeding in the dark!
Wholesale Price China Bioantibody - Promote Drug Development Process – Bioantibody Detail:

General Information

Bioantibody first-in-class and best-in-class portfolio is designed to address significant unmet medical needs through the development of mono and bi-specific protein therapeutics, antibody drug conjugates and macrophage stimulating agents for patients worldwide.

History

The ground-breaking discovery of monoclonal antibody (mAb) technology by Kohler and Milstein in 1975 provided the possibility of creating antibodies as a class of therapeutics (Kohler & Milstein, 1975). Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious diseases or cancer therapeutics because they selectively target pathogens, infectious cells, cancerous cells, and even immune cells. In this way, they mediate the elimination of target molecules and cells with fewer side effects than other therapeutic modalities. In particular, cancer therapeutic mAbs can recognize cell-surface proteins on target cells and then kill the targeted cells by multiple mechanisms.
Humanization greatly reduces a therapeutic antibody’s immunogenicity in humans, making chronic administration possible. Such advances in antibody technologies have resulted in an explosion in the development of therapeutic mAbs over the last decade. A series of antibody derivatives, which include Fc-fusion proteins, antibody-drug conjugates (ADCs), immunocytokines (antibody-cytokine fusions), and antibody-enzyme fusions, are also developed and commericialized as a new treatment.

Drug effects

For patients, new targeted drugs mean fewer side effects, fewer hospitalizations, improved quality of life, increased productivity, and importantly, extended lives. But drug development is a long, complex process.

Reference

Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–497. doi: 10.1038/256495a0
Ecker DM, Jones SD, Levine HL. The therapeutic monoclonal antibody market. MAbs. 2015;7:9–14. doi: 10.4161/19420862.2015.989042.
Peters C, Brown S. Antibody-drug conjugates as novel anti-cancer chemotherapeutics. Biosci Rep. 2015;35(4):e00225. Published 2015 Jul 14. Available at https://pubmed.ncbi.nlm.nih.gov/26182432/. Accessed July 2020.
Reichert, J.M., and Valge-Archer, V.E. (2007). Development trends for monoclonal antibody cancer therapeutics. Nat Rev Drug Discov 6, 349–356.
Lazar, G.A., Dang, W., Karki, S., Vafa, O., Peng, J.S., Hyun, L., Chan, C., Chung, H.S., Eivazi, A., Yoder, S.C., et al. (2006). Engineered antibody Fc variants with enhanced effector function. PNAS 103, 4005–4010.


Product detail pictures:

Wholesale Price China Bioantibody - Promote Drug Development Process – Bioantibody detail pictures


Related Product Guide:

Our items are commonly identified and trusted by customers and may fulfill continuously switching economic and social wants of Wholesale Price China Bioantibody - Promote Drug Development Process – Bioantibody , The product will supply to all over the world, such as: Kenya, Norway, Brunei, Besides strong technical strength, we also introduce advanced equipment for inspection and conduct strict management. All the staff of our company welcome friends both at home and abroad to come for visits and business on the basis of equality and mutual benefit. If you are interested in any of our items, please feel free to contact us for quotation and product details.
  • The enterprise has a strong capital and competitive power, product is sufficient, reliable, so we have no worries on cooperating with them.
    5 Stars By Rebecca from United Kingdom - 2018.06.28 19:27
    Staff is skilled, well-equipped, process is specification, products meet the requirements and delivery is guaranteed, a best partner!
    5 Stars By Julie from Barbados - 2018.09.08 17:09
    Write your message here and send it to us